COVID-19

COVID-19

COVID-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus 2.

Symptoms of COVID-19 are variable, but often include fever, cough, fatigue, breathing difficulties, and loss of smell and taste. Symptoms begin one to fourteen days after exposure to the virus. Multi-year studies are underway to further investigate the long-term effects of the disease.

To enhance your search results you can use the various filters available such as mode (online/ on-site).

 

 

Discover the Covid-19 courses/events

60 Courses/ Events
TREATING COVID-19 PATIENTS: MODERATE AND SEVERE; COMPLICATIONS IN THESE CASES

  HIGHLIGHTS OF THE WEBINAR MODULE 1 - Overview of COVID-19, Dr B B Revari (30min) •Microbiology of corona virus, virus history with types and pathophysiology. •Description of t...

   Online
English
Oct 11, 2020 to Oct 10, 2024
TREATING MILD TO SEVERE COVID-19 PATIENTS

IMA Chandigarh welcomes you to recorded webinar session on “Treating Mild to Severe COVID-19 Patients” What was covered: Introduction of panelist: Dr. Mayuri Keskar, MLH & TC4A...

   Online
English
Oct 10, 2020 to Oct 09, 2024
USE OF REMDESIVIR IN TREATING PATIENTS WITH COVID-19 (EXPERIENCE SHARING & UPDATES FROM CLINICAL TRIALS)

IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)" Intro...

   Online
English
Oct 09, 2020 to Oct 08, 2024
REMDESIVIR FOR TREATMENT OF COVID-19 PATIENTS

  Remdesivir , is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease....

   Online
English
Sep 30, 2020 to Sep 29, 2024
BENEFIT OF EARLY INTERVENTION & ROLE OF FAVIPIRAVIR IN MANAGING MILD TO MODERATE COVID-19 DISEASE

  As the incidence of COVID-19 cases continue to rise, we will need multiple approaches to effectively deal with this pandemic. Clinicians are evaluating Favipiravir for use in mild-to-moderat...

amount-icon
FREE
   Online
English
Sep 19, 2020 to Sep 18, 2024
CLINICAL & PULMONARY COVID-19 COMPLICATIONS; EXPERIENCE SHARING IN MANAGING THROUGH RECOVERY (INCLUDING PSYCHIATRY STRESS)

  Indian Medical Association Rajasthan (IMA Raj) welcomes doctors to view a recorded session on “Clinical & Pulmonary COVID-19 complications” held on 13th Sep 2020, where...

   Online
English
Sep 13, 2020 to Sep 12, 2022
CLINICAL EXPERIENCE SHARING: TREATING ADULT AND PEDIATRIC COVID-19 PATIENTS & UPDATES ON REMDESIVIR

Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge.  Indian Medical Association Ma...

   Online
English
Sep 09, 2020 to Sep 08, 2022
CLINICAL EXPERIENCE SHARING ON THE USE OF REMDESIVIR

In India, Remdesivir has been approved for emergency use in patients hospitalized with severe COVID-19. There is a need to understand and share experience on the use of this drug. We welcome you to vi...

   Online
English
Aug 23, 2020 to Aug 22, 2022
THE RACE FOR COVID-19 TREATMENT, CLINICAL TRIAL OUTCOMES & EXPERT PERSPECTIVES

The challenges of conducting trials against the backdrop of the COVID-19 pandemic will continue as we collectively journey into the “new normal”.  Welcome to the recorded webinar on &...

   Online
English
Aug 16, 2020 to Aug 15, 2022







Account